查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2010004

生物材料市場：按類型、分類、最終用戶和應用分類－2026-2032年全球市場預測

Biomaterials Market by Type, Classification, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物材料市場價值將達到 560.7 億美元，到 2026 年將成長至 630.2 億美元，到 2032 年將達到 1,313 億美元，複合年成長率為 12.92%。

主要市場統計數據
基準年 2025 560.7億美元
預計年份：2026年 630.2億美元
預測年份 2032 1313億美元
複合年成長率 (%) 12.92%

全面概述了塑造生物材料產業的當前趨勢、核心技術基礎和前沿研究。

生物材料已成為現代醫學的關鍵基石，推動了組織工程、藥物傳輸和醫療設備創新等領域的突破性進展。近年來，聚合物化學、陶瓷複合材料和金屬合金等領域的進步融合，拓展了植入和再生醫學的功能。本文概述了生物材料在改善患者預後和促進材料科學家、臨床醫生和製造專家之間的跨學科合作方面所發揮的關鍵作用。

新一代材料、先進製造技術和協作創新模式推動了生物材料開發的革命性變革。

在新一代材料和創新製造技術的推動下，生物材料領域正經歷快速變化。積層製造技術的進步使得快速植入複雜植入物原型成為可能，同時確保了高度可重複的品質標準。同時，奈米技術的突破也使得表面改質變得更加容易，從而增強細胞黏附並促進癒合反應。

評估2025年生效的美國新關稅對生醫材料市場供應鏈、成本結構和競爭力的累積影響。

美國2025年實施的新關稅預計將重塑生醫材料市場供應鏈，影響關鍵原料的成本和供應。從主要製造地進口的陶瓷和特殊金屬合金可能面臨更高的關稅負擔，導致下游醫療設備製造商的生產成本上升。為因應此問題，各公司正在探索替代籌資策略，包括近岸外包和雙重採購，以降低貿易波動帶來的風險。

對生物材料市場進行深入分析，從材料類型、分類、最終用戶和各種應用領域入手，推動策略重點。

生物材料市場的細分分析揭示了材料類型、功能分類、使用者群體和應用領域等方面的明確機會。就材料類型而言，氧化鋁、生物玻璃、羥磷石灰和氧化鋯等陶瓷材料在硬組織植入中仍然至關重要，而金屬基材仍然是承重關節重建的基礎。天然聚合物以其生物相容性優勢補充了這些分類，而從聚己內酯到聚乳酸-羥基乙酸共聚物和聚乙烯醇等合成聚合物則為支架設計和藥物遞送基質提供了多樣化的選擇。

策略區域洞察：揭示美洲、歐洲、中東、非洲和亞太地區生醫材料生態系統的成長動態和市場促進因素

區域趨勢對於理解生物材料產業的發展演變至關重要。在美洲，完善的基礎設施和大量的研發投入建構了一個有利於產品快速開發和臨床試驗的生態系統。北美監管體係以系統化的核准流程為特徵，為創新者提供了清晰的藍圖；而拉丁美洲市場則在醫療保健覆蓋範圍擴大和改革舉措的推動下，創造了新的機會。

企業洞察，重點在於競爭考察、創新管道以及領先生醫材料供應商之間的夥伴關係。

生物材料領域的主要企業正透過整合創新管線和策略合作實現差異化競爭。以全球佈局著稱的大型醫療設備製造商正利用其專有的生物活性塗層和先進的聚合物配方技術拓展產品線。同時，特種化學品製造商正憑藉其在高純度材料方面的專業知識，滿足嚴格的生物相容性要求，並擴大其在臨床市場的佔有率。

為產業領導者提供實用建議，幫助他們利用新興趨勢、最佳化供應鏈，並透過策略舉措鞏固市場地位。

產業領導者應優先投資生物活性和再生醫學材料，以滿足尚未滿足的臨床需求，並利用與研究機構的合作來加速轉化研究。透過在產品開發中採用模組化方法，企業可以在將各個組件整合到綜合治療平台之前進行單獨檢驗，從而縮短產品上市時間並降低技術風險。

採用穩健的調查方法，強調全面的資料收集、多方面的資訊匹配以及嚴格的定性和定量分析，以確保可靠性。

本分析採用嚴謹的調查方法，結合了全面的二手資料研究、針對性的一手訪談和資料檢驗。公開的科學文獻、監管文件和專利資料庫為材料創新和市場趨勢提供了重要的見解。除上述資訊來源外，本分析還補充了對材料科學家、生物醫學工程師以及供應鏈和臨床機構高級決策者的訪談。

這總結了關鍵發現，突顯了市場機遇，並提供了明確的見解，從而強化了生物材料相關人員的策略重點。

研究結果凸顯了技術創新、監管演變和全球貿易趨勢之間動態的相互作用，這些因素共同塑造著生醫材料產業。變革性的製造方法和協同創新生態系統正在重新定義性能標準，而新關稅體系的引入則需要對供應鏈網路進行積極主動的重組。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：生物材料市場：依類型分類

  • 陶瓷
    • 氧化鋁
    • 生物玻璃
    • 羥磷石灰
    • 氧化鋯
  • 金屬
  • 自然的
  • 合成聚合物
    • PCL（聚己內酯​​）
    • PGA（聚乙醇酸）
    • PLA（聚乳酸）
    • PLGA（聚乳酸-羥基乙酸共聚物）
    • 聚乙烯（PE）
    • 聚丙烯（PP）
    • 聚氨酯（PU）
    • 聚乙烯醇（PVA）

第9章：生物材料市場分類

  • 生物活性物質
  • 生物相容性材料
  • 惰性材料

第10章：生物材料市場：依最終用戶分類

  • 生技公司
  • 醫院
  • 研究所
  • 專科診所

第11章：生物材料市場：依應用領域分類

  • 循環系統
    • 導管導引線
    • 植入式心臟去心房顫動
    • 心律調節器
    • 感應器
    • 支架
    • 血管移植
  • 牙科
    • 骨移植材料和骨替代物
    • 人工植牙
    • 牙膜
    • 組織再生材料
  • 眼科
  • 整形外科
    • 生物可吸收組織固定產品
    • 用於關節重建的生物材料
    • 整形外科生物製劑
    • 用於脊椎的生物材料
    • 關節內粘稠補充療法
  • 泌尿系統
  • 創傷治療
    • 防沾黏材料
    • 骨折癒合裝置
    • 內組織密封膠
    • 皮膚替代材料
    • 外科止血材料

第12章：生物材料市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：生物材料市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：生物材料市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國生物材料市場

第16章：中國生物材料市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aroa Biosurgery Limited
  • BASF SE
  • Berkeley Advanced Biomaterials Inc.
  • Bezwada Biomedical, LLC
  • Carpenter Technology Corporation
  • Celanese Corporation
  • CoorsTek, Inc.
  • Corbion NV
  • Covestro AG
  • Dentsply Sirona Inc.
  • DSM-Firmenich AG
  • Evonik Industries AG
  • Exactech, Inc.
  • Heraeus Holding GmbH
  • Invibio Limited
  • Medtronic plc
  • Modern Meadow, Inc.
  • MycoWorks, Inc.
  • Noble Biomaterials, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • TissueForm, Inc.
Product Code: MRR-434CCDA04CCF

The Biomaterials Market was valued at USD 56.07 billion in 2025 and is projected to grow to USD 63.02 billion in 2026, with a CAGR of 12.92%, reaching USD 131.30 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 56.07 billion
Estimated Year [2026] USD 63.02 billion
Forecast Year [2032] USD 131.30 billion
CAGR (%) 12.92%

Comprehensive Introduction Uncovering the Current Biomaterials Landscape, Core Technology Foundations, and Emerging Research Frontiers Shaping the Industry

Biomaterials have emerged as a pivotal cornerstone in modern healthcare, enabling breakthroughs across tissue engineering, drug delivery, and medical device innovation. In recent years, advances in polymer chemistry, ceramic composites, and metallic alloys have converged to broaden the functional capabilities of implants and regenerative therapies. This introduction provides a foundation for understanding the critical role of biomaterials in enhancing patient outcomes and driving cross-disciplinary collaboration between material scientists, clinicians, and manufacturing specialists.

Emerging research is redefining traditional boundaries, with bioactive ceramics and composite scaffolds integrating biological cues that mimic native tissue microenvironments. Meanwhile, novel metallic frameworks are being engineered to reduce inflammatory responses and improve long-term biocompatibility. In parallel, synthetic polymers are evolving to balance mechanical strength with controlled biodegradation profiles, enabling precision in tissue regeneration protocols.

The interplay between clinical need and material innovation is accelerating the development of personalized solutions, from patient-specific implants to tailored drug delivery platforms. Through understanding both foundational science and applied engineering advances, stakeholders can chart strategic roadmaps that anticipate future demands while mitigating risks inherent in novel product introductions. As we transition into this report, you will gain insights into transformative shifts, trade impacts, segmentation dynamics, and regional nuances shaping the biomaterials landscape.

Revolutionary Transformative Shifts in Biomaterials Development Fueled by Next-Generation Materials, Advanced Manufacturing Techniques, and Collaborative Innovation Models

The biomaterials sector is undergoing a period of rapid transformation driven by next-generation materials and novel manufacturing techniques. Advances in additive manufacturing now enable rapid prototyping of complex implant geometries while ensuring repeatable quality standards. Simultaneously, breakthroughs in nanotechnology are facilitating surface modifications that enhance cellular adhesion and promote accelerated healing responses.

Collaborative innovation models are redefining how academic institutions, start-ups, and established medical device manufacturers co-develop new solutions. By integrating data from real-world evidence platforms and leveraging artificial intelligence algorithms, research teams can optimize material compositions for specific clinical applications more efficiently than ever before. This convergence of digital and materials science is influencing regulatory frameworks, prompting agencies to adopt flexible pathways for validating combination products.

Moreover, sustainability considerations are gaining prominence, prompting industry leaders to explore bio-derived polymers and recyclable composites. The drive toward circular economies is reinforcing investments in biodegradable scaffolds and eco-friendly sourcing practices. Together, these shifts signal a paradigm in which innovation is not only measured by functional performance but also by environmental stewardship and collaborative agility.

Assessing the Cumulative Consequences of New United States Tariffs in 2025 on Supply Chains, Cost Structures, and Competitive Positioning within the Biomaterials Market

The introduction of new United States tariffs in 2025 is poised to reshape the biomaterials supply chain, affecting the cost and availability of critical raw inputs. Ceramics imported from key manufacturing hubs, alongside specialized metallic alloys, may experience increased duty burdens that translate into higher production costs for downstream device manufacturers. In response, companies are evaluating alternative sourcing strategies, including near-shoring and dual-sourcing, to mitigate exposure to trade volatility.

At the same time, synthetic polymers such as PCL and PLA, often produced in regions targeted by the tariffs, could see lead-time fluctuations and margin contractions. This will encourage strategic inventory management and potential consolidation of supplier portfolios. Emerging markets in Europe and Asia Pacific are already positioning themselves as alternative production centers, investing in capacity expansion to capture redirected demand flows.

Despite these challenges, the industry continues to innovate through cost-optimization programs and by exploring tariff classification strategies that align with evolving trade regulations. Companies that proactively engage with customs authorities and diversify their supplier base will be better equipped to absorb short-term shocks and maintain competitive pricing for medical device end users.

Insightful Analysis of Biomaterials Market Segmentation Based on Material Type, Classification, End Users, and Diverse Application Domains Driving Strategic Focus

Analysis of biomaterials market segmentation reveals distinct areas of opportunity tied to material type, functional classification, user groups, and application specialties. Within material type, ceramics such as alumina, bioglass, hydroxyapatite, and zirconia remain pivotal for hard-tissue implants, while metallic substrates continue to underpin load-bearing joint replacements. Natural polymers complement these classes by offering biocompatibility advantages, and synthetic polymers-ranging from polycaprolactone through polylactic-co-glycolic acid to polyvinyl alcohol-provide versatile options for scaffold design and drug delivery matrices.

When considering functional classification, bioactive materials lead in regenerative therapies by actively interacting with biological environments to stimulate tissue growth. Biocompatible materials offer inert scaffolding solutions for long-term implant stability, and bioinert variants provide durable interfaces for devices where tissue response must be minimized. This classification framework guides material selection across diverse biomedical use cases.

End-user segmentation segments the market among biotechnology companies pursuing R&D breakthroughs, hospitals implementing clinical solutions, research laboratories pioneering novel protocols, and specialty clinics delivering targeted therapeutic interventions. Application domains further refine strategic focus areas, with cardiovascular devices-spanning guidewires to vascular grafts-dental innovations from bone graft substitutes to tissue regeneration materials, orthopedic implants including joint replacements and orthobiologics, urinary device technologies, and wound healing systems such as adhesion barriers and surgical hemostats driving specific growth trajectories.

Strategic Regional Insights Unveiling Growth Dynamics and Market Drivers across the Americas, Europe Middle East and Africa, and Asia Pacific Biomaterials Ecosystems

Regional dynamics are central to understanding the biomaterials industry's evolution. In the Americas, robust infrastructure and significant R&D investments create an ecosystem conducive to rapid product development and clinical trials. North American regulatory pathways, characterized by structured approval processes, foster a clear roadmap for innovators, while Latin American markets provide emerging opportunities driven by expanding healthcare access and reform initiatives.

Across Europe, the Middle East, and Africa, diversity in regulatory standards and economic maturity presents both complexity and opportunity. Western Europe's established medical device directives underpin high-value transactions, whereas emerging markets in Eastern Europe and the Gulf region are growing through targeted public-private partnerships and infrastructure enhancements. Africa's nascent healthcare systems are incrementally adopting biomaterial-based interventions, driven by international funding and local capacity building.

The Asia Pacific region stands out for its rapid adoption of advanced healthcare technologies and cost-competitive manufacturing capabilities. Countries in East and Southeast Asia are expanding production hubs for both ceramics and polymers, while regulatory authorities in the region are streamlining approval pathways to attract global investment. Together, these regional ecosystems define the contours of global value chains and strategic market positioning.

Key Company Insights Highlighting Competitive Strategies, Innovation Pipelines, and Collaborative Partnerships Among Leading Biomaterials Providers

Leading companies in the biomaterials sector are differentiating through integrated innovation pipelines and strategic collaborations. Major medical device players, known for extensive global footprints, are augmenting their offerings with proprietary bioactive coatings and advanced polymer formulations. Simultaneously, specialty chemical manufacturers are expanding into clinical markets, leveraging expertise in high-purity materials to meet stringent biocompatibility requirements.

Partnerships between academic institutions and commercial enterprises are accelerating technology transfer, enabling start-ups to scale novel scaffold designs from benchtop validation to regulatory submission. These alliances often involve joint venturing for pilot manufacturing sites and co-development agreements that align intellectual property strategies with market entry timelines. Moreover, several established firms are undertaking targeted acquisitions to fill gaps in regenerative medicine portfolios and reinforce competitive barriers.

Investment trends indicate a growing focus on scalable manufacturing processes, lean supply chains, and digital quality management systems. Companies that optimize their global networks to balance cost efficiency with regulatory compliance will maintain an edge. In parallel, engagement with key opinion leaders and participation in international standards committees reinforce credibility and facilitate market acceptance of next-generation biomaterial solutions.

Actionable Recommendations for Industry Leaders to Capitalize on Emerging Trends, Optimize Supply Chains, and Strengthen Market Position through Strategic Initiatives

Industry leaders should prioritize investment in bioactive and regenerative materials that address unmet clinical needs, leveraging partnerships with research institutions to accelerate translational research. By adopting a modular approach to product development, organizations can validate components individually before integrating them into comprehensive therapy platforms, reducing time to market and mitigating technical risk.

Optimizing supply chains is equally critical. Companies should evaluate dual-sourcing strategies for key raw materials, while exploring near-shoring options to reduce exposure to trade disruptions and shorten lead times. Implementing advanced analytics across procurement and logistics operations will enable real-time visibility, supporting proactive decision-making in response to tariff changes or supplier constraints.

To strengthen market positioning, leadership teams must engage regulatory bodies early in the development lifecycle, seeking alignment on clinical trial design and material characterization requirements. Additionally, pursuing sustainability initiatives-such as recyclable packaging and bio-derived polymer research-will resonate with stakeholder expectations and regulatory trends. Finally, fostering cross-disciplinary talent development programs ensures that internal teams possess the expertise needed to navigate emerging technologies and shifting market dynamics.

Robust Research Methodology Emphasizing Comprehensive Data Collection, Multisource Triangulation, and Rigorous Qualitative and Quantitative Analyses Ensuring Reliability

This analysis leverages a robust research methodology combining comprehensive secondary research with targeted primary interviews and data validation. Publicly available scientific literature, regulatory filings, and patent databases provided foundational insights into material innovations and market developments. These sources were augmented by interviews with material scientists, biomedical engineers, and executive-level decision-makers across supply chain and clinical organizations.

Quantitative data on production volumes, trade flows, and patent filings were triangulated to validate emerging trends, while qualitative feedback from industry stakeholders informed strategic assessments. A rigorous segmentation framework was developed to capture the nuances of material type, functional classification, end-user categories, and application areas.

Throughout the research process, cross-verification mechanisms ensured data integrity, including consistency checks against multiple independent sources and alignment with regional regulatory standards. Competitive benchmarking and scenario analysis were employed to stress-test potential market disruptions, such as tariff impacts and supply chain constraints. This systematic approach underpins the reliability and actionable nature of the insights presented.

Conclusive Insights Synthesizing Key Findings, Highlighting Market Opportunities, and Reinforcing Strategic Priorities for Biomaterials Stakeholders

The findings presented underscore the dynamic interplay of technological innovation, regulatory evolution, and global trade dynamics shaping the biomaterials sector. Transformative manufacturing approaches and collaborative innovation ecosystems are redefining performance benchmarks, while emerging tariff regimes necessitate proactive supply network realignment.

Segmentation insights reveal that targeted investment in bioactive and specialty polymer domains, coupled with strategic engagement of key end-user channels, will unlock high-value opportunities. Regional variations in regulatory complexity and manufacturing capacity highlight the importance of bespoke market entry strategies and localized partnerships.

By integrating these strategic imperatives with agile planning and sustained R&D commitment, companies can position themselves to lead in an environment characterized by rapid scientific advancement and shifting geopolitical landscapes. The path forward requires a balance of innovation, operational resilience, and strategic foresight to drive sustained growth and deliver transformative patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biomaterials Market, by Type

  • 8.1. Ceramics
    • 8.1.1. Alumina
    • 8.1.2. Bioglass
    • 8.1.3. Hydroxyapatite
    • 8.1.4. Zirconia
  • 8.2. Metallic
  • 8.3. Natural
  • 8.4. Synthetic Polymers
    • 8.4.1. PCL (Polycaprolactone)
    • 8.4.2. PGA (Polyglycolic acid)
    • 8.4.3. PLA (Polylactic acid)
    • 8.4.4. PLGA (Polylactic-co-glycolic acid)
    • 8.4.5. Polyethylene (PE)
    • 8.4.6. Polypropylene (PP)
    • 8.4.7. Polyurethane (PU)
    • 8.4.8. Polyvinyl alcohol (PVA)

9. Biomaterials Market, by Classification

  • 9.1. Bioactive Materials
  • 9.2. Biocompatible Materials
  • 9.3. Bioinert Materials

10. Biomaterials Market, by End User

  • 10.1. Biotechnology Companies
  • 10.2. Hospitals
  • 10.3. Research Laboratories
  • 10.4. Specialty Clinics

11. Biomaterials Market, by Application

  • 11.1. Cardiovascular
    • 11.1.1. Guidewires
    • 11.1.2. Implantable Cardiac Defibrillators
    • 11.1.3. Pacemakers
    • 11.1.4. Sensors
    • 11.1.5. Stents
    • 11.1.6. Vascular Grafts
  • 11.2. Dental
    • 11.2.1. Bone Grafts & Substitutes
    • 11.2.2. Dental Implants
    • 11.2.3. Dental Membranes
    • 11.2.4. Tissue Regeneration Materials
  • 11.3. Ophthalmology
  • 11.4. Orthopedic
    • 11.4.1. Bioresorbable Tissue Fixation Products
    • 11.4.2. Joint Replacement biomaterials
    • 11.4.3. Orthobiologics
    • 11.4.4. Spine Biomaterials
    • 11.4.5. Viscosupplementation
  • 11.5. Urinary
  • 11.6. Wound Healing
    • 11.6.1. Adhesion Barrier
    • 11.6.2. Fracture Healing Device
    • 11.6.3. Internal Tissue Sealant
    • 11.6.4. Skin Substitutes
    • 11.6.5. Surgical Hemostats

12. Biomaterials Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biomaterials Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biomaterials Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Biomaterials Market

16. China Biomaterials Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aroa Biosurgery Limited
  • 17.6. BASF SE
  • 17.7. Berkeley Advanced Biomaterials Inc.
  • 17.8. Bezwada Biomedical, LLC
  • 17.9. Carpenter Technology Corporation
  • 17.10. Celanese Corporation
  • 17.11. CoorsTek, Inc.
  • 17.12. Corbion N.V.
  • 17.13. Covestro AG
  • 17.14. Dentsply Sirona Inc.
  • 17.15. DSM-Firmenich AG
  • 17.16. Evonik Industries AG
  • 17.17. Exactech, Inc.
  • 17.18. Heraeus Holding GmbH
  • 17.19. Invibio Limited
  • 17.20. Medtronic plc
  • 17.21. Modern Meadow, Inc.
  • 17.22. MycoWorks, Inc.
  • 17.23. Noble Biomaterials, Inc.
  • 17.24. Smith & Nephew plc
  • 17.25. Stryker Corporation
  • 17.26. TissueForm, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOMATERIALS MARKET SIZE, BY ALUMINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY ALUMINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY ALUMINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOGLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOGLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOGLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOMATERIALS MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOMATERIALS MARKET SIZE, BY HYDROXYAPATITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOMATERIALS MARKET SIZE, BY HYDROXYAPATITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOMATERIALS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOMATERIALS MARKET SIZE, BY ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOMATERIALS MARKET SIZE, BY ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOMATERIALS MARKET SIZE, BY METALLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOMATERIALS MARKET SIZE, BY METALLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOMATERIALS MARKET SIZE, BY METALLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOMATERIALS MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOMATERIALS MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOMATERIALS MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOMATERIALS MARKET SIZE, BY PCL (POLYCAPROLACTONE), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOMATERIALS MARKET SIZE, BY PCL (POLYCAPROLACTONE), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOMATERIALS MARKET SIZE, BY PCL (POLYCAPROLACTONE), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOMATERIALS MARKET SIZE, BY PGA (POLYGLYCOLIC ACID), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOMATERIALS MARKET SIZE, BY PGA (POLYGLYCOLIC ACID), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOMATERIALS MARKET SIZE, BY PGA (POLYGLYCOLIC ACID), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOMATERIALS MARKET SIZE, BY PLA (POLYLACTIC ACID), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOMATERIALS MARKET SIZE, BY PLA (POLYLACTIC ACID), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOMATERIALS MARKET SIZE, BY PLA (POLYLACTIC ACID), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOMATERIALS MARKET SIZE, BY PLGA (POLYLACTIC-CO-GLYCOLIC ACID), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOMATERIALS MARKET SIZE, BY PLGA (POLYLACTIC-CO-GLYCOLIC ACID), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOMATERIALS MARKET SIZE, BY PLGA (POLYLACTIC-CO-GLYCOLIC ACID), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYETHYLENE (PE), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYETHYLENE (PE), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYETHYLENE (PE), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYPROPYLENE (PP), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYPROPYLENE (PP), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYURETHANE (PU), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYURETHANE (PU), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYURETHANE (PU), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOACTIVE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOACTIVE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOACTIVE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOINERT MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOINERT MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOINERT MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOMATERIALS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOMATERIALS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOMATERIALS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOMATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOMATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOMATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOMATERIALS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOMATERIALS MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOMATERIALS MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOMATERIALS MARKET SIZE, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOMATERIALS MARKET SIZE, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOMATERIALS MARKET SIZE, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOMATERIALS MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOMATERIALS MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOMATERIALS MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOMATERIALS MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOMATERIALS MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOMATERIALS MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOMATERIALS MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOMATERIALS MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOMATERIALS MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOMATERIALS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOMATERIALS MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOMATERIALS MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOMATERIALS MARKET SIZE, BY BONE GRAFTS & SUBSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOMATERIALS MARKET SIZE, BY BONE GRAFTS & SUBSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOMATERIALS MARKET SIZE, BY BONE GRAFTS & SUBSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL MEMBRANES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL MEMBRANES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL MEMBRANES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIOMATERIALS MARKET SIZE, BY TISSUE REGENERATION MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOMATERIALS MARKET SIZE, BY TISSUE REGENERATION MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIOMATERIALS MARKET SIZE, BY TISSUE REGENERATION MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BIOMATERIALS MARKET SIZE, BY BIORESORBABLE TISSUE FIXATION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOMATERIALS MARKET SIZE, BY BIORESORBABLE TISSUE FIXATION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BIOMATERIALS MARKET SIZE, BY BIORESORBABLE TISSUE FIXATION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT BIOMATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT BIOMATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT BIOMATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOMATERIALS MARKET SIZE, BY SPINE BIOMATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BIOMATERIALS MARKET SIZE, BY SPINE BIOMATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOMATERIALS MARKET SIZE, BY SPINE BIOMATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOMATERIALS MARKET SIZE, BY URINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BIOMATERIALS MARKET SIZE, BY URINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOMATERIALS MARKET SIZE, BY URINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BIOMATERIALS MARKET SIZE, BY ADHESION BARRIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOMATERIALS MARKET SIZE, BY ADHESION BARRIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BIOMATERIALS MARKET SIZE, BY ADHESION BARRIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOMATERIALS MARKET SIZE, BY FRACTURE HEALING DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BIOMATERIALS MARKET SIZE, BY FRACTURE HEALING DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOMATERIALS MARKET SIZE, BY FRACTURE HEALING DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BIOMATERIALS MARKET SIZE, BY INTERNAL TISSUE SEALANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOMATERIALS MARKET SIZE, BY INTERNAL TISSUE SEALANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BIOMATERIALS MARKET SIZE, BY INTERNAL TISSUE SEALANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOMATERIALS MARKET SIZE, BY SKIN SUBSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BIOMATERIALS MARKET SIZE, BY SKIN SUBSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOMATERIALS MARKET SIZE, BY SKIN SUBSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BIOMATERIALS MARKET SIZE, BY SURGICAL HEMOSTATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOMATERIALS MARKET SIZE, BY SURGICAL HEMOSTATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL BIOMATERIALS MARKET SIZE, BY SURGICAL HEMOSTATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS BIOMATERIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 260. GCC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. GCC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. GCC BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 268. GCC BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 269. GCC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 270. GCC BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 293. G7 BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. G7 BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 296. G7 BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 297. G7 BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 298. G7 BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. G7 BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. G7 BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 301. G7 BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 302. G7 BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 303. G7 BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 304. NATO BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 305. NATO BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. NATO BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 307. NATO BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 308. NATO BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 309. NATO BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. NATO BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. NATO BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 312. NATO BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 313. NATO BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 314. NATO BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 315. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA BIOMATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 335. CHINA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 336. CHINA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 337. CHINA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)